Trials / Completed
CompletedNCT01320761
A Study to Assess Injection Comfort of Two Formulations of ATX-101
A Study to Assess Injection Comfort of Two Formulations of ATX-101 (Sodium Deoxycholate Injection) Following Subcutaneous Administration in the Submental Area
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Kythera Biopharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To assess the safety and injection comfort of ATX-101-BA versus ATX-101-BA-free immediately following injection and at regular intervals up to 24-hours post-injection following subcutaneous administration into the submental area.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ATX-101-BA-free | ATX-101-BA-free |
| DRUG | ATX-101-BA | ATX-101-BA |
Timeline
- First posted
- 2011-03-22
- Last updated
- 2011-03-22
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01320761. Inclusion in this directory is not an endorsement.